article thumbnail

CBD: Everything You Need to Know

CannaMD

government classified all cannabis varieties, including hemp, as Schedule I under the Controlled Substances Act (despite decades of agricultural research detailing its differences from marijuana). Prior to receiving FDA approval, Epidiolex underwent a number of clinical trials establishing the medical efficacy of CBD.

CBD 99
article thumbnail

First ethics at MAPS in question and now Australia’s Mind Medicine look to have some serious integrity issues too

Cannabis Law Report

Reporter Elise Worthington also investigates the dark side of this form of therapy where disturbing cases of abuse and malpractice are emerging in both clinical trials and the underground. military officers at the National Defense University in Washington DC from 2004 till 2010. Here’s the precis to the show.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

A Hidden Origin Story of the CBD Craze

SMPL

In June of 2010, the host of the 2011 summit, the biochemist Ms. In the fall of 2010, a Project CBD website was set up where anyone could look through studies organized by disease or condition. fast-tracked clinical trials of GW Pharmaceuticals’ 98 percent CBD drug, Epidiolex. Lee, the writer.

CBD 40
article thumbnail

Paper: The transition of cannabis into the mainstream of Australian healthcare: framings in professional medical publications

Cannabis Law Report

However, from 2010, a dramatic increase is observable in articles about medicinal cannabis in the publications under analysis. It is unclear whether doctors are feeling completely reassured by laboratory and clinical trial research into medicinal cannabis. Oxford: Wiley-Blackwell; 2010. In: Cockerham WC, editor.

article thumbnail

Psychedelic Invest’s 100 Most Influential People in Psychedelics List

Cannabis Law Report

Rick, and MAPS, have published hundreds of research papers, articles, and reports over the past several decades in addition to participation in dozens of clinical trials and international studies. He is the chairman of Drug Science, a non-profit which he founded in 2010 to provide independent, evidence-based information on drugs.

article thumbnail

Report: “Key pharmacological differences between side effects of refined, pharmaceutical CBD formulations and whole plant extracts:”

Cannabis Law Report

Recent studies on the effectiveness of cannabidiol in the rare seizure disorders Dravet Syndrome and Lennox-Gastaut syndrome have prompted a biopharmaceutical company to perform clinical trials of its own to bring a cannabidiol based drug to the American market through the process of FDA approval. YANINA PEPINO, PHD COURTNEY D.

article thumbnail

Meritas Law Firms Worldwide Article: Global Cannabis Industry: The Essential Primer

Cannabis Law Report

Once the provisions of the Farm Bill are fully implemented, the whole plant could be grown anywhere in any state that participates in the Department of Agriculture’s cultivation plan, or adopts its own, and shipped across state borders. Mexico is an interesting case.

Law 40